A dendritic cell-based vaccine effects on T-cell responses compared with a viral vector vaccine when administered to patients following resection of colorectal metastases in a randomized phase II study.
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2011-06-04 / J Clin Oncol 29: 2011 (suppl; abstr 2533)Survival rates among patients vaccinated following resection of colorectal cancer metastases in a phase II randomized study compared with contemporary controls.
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2011-06-04 / J Clin Oncol 29: 2011 (suppl; abstr 3557)Immuno-cell therapy with antecedent surgery has superior actuarial survival to immuno-cell therapy without antecedent surgery for advanced cancers
/in Dendritic Cells, International Publications /von 2011-06-03 / Cancer Immunol. Immunother. 2011 Oct;60(10):1397-403PD-1 blockade by CT-011, anti-PD-1 antibody, enhances ex vivo T-cell responses to autologous dendritic cell/myeloma fusion vaccine
/in Checkpoint-Inhibitors, Dendritic Cells, International Publications /von 2011-06-01 / J. Immunother. 2011 Jun;34(5):409-18Cancer stem cells: perspectives of new therapeutical approaches for breast cancer
/in Breast Cancer, Dendritic Cells, International Publications /von 2011-06-01 / Front Biosci (Schol Ed) 2011 Jun;3:1486-99Engineering the brain tumor microenvironment enhances the efficacy of dendritic cell vaccination: implications for clinical trial design
/in Dendritic Cells, Glioblastoma, International Publications /von 2011-06-01 / Clin. Cancer Res. 2011 Jul;17(14):4705-18Immunotherapy for the treatment of prostate cancer
/in Dendritic Cells, International Publications, Prostate Cancer /von 2011-05-24 / Nat Rev Clin Oncol 2011 May;8(9):551-61Cancer-testis antigen, BORIS based vaccine delivered by dendritic cells is extremely effective against a very aggressive and highly metastatic mouse mammary carcinoma
/in Dendritic Cells, International Publications /von 2011-05-12 / Cell. Immunol. 2011;270(2):188-97Randomized trial of autologous cellular immunotherapy with sipuleucel-T in androgen-dependent prostate cancer
/in Dendritic Cells, International Publications, Prostate Cancer /von 2011-05-10 / Clin. Cancer Res. 2011 Jul;17(13):4558-67
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de